In the present investigation, we examined whether promoting TrkB and TrkC signaling with the small molecule ligand BD10‐2 can reduce measures of synaptic integrity decline observed in the hAPPLond/Swe (APPL/S) mouse model of AD. This evidence concerns the gene NTRK2 and Alzheimer disease.